Related Experiment Video
Updated: Sep 27, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
[Antibiotic sensitivity of Streptococcus pyogenes in pediatrics]
A Gené1, A González-Cuevas, T Juncosa
1Servicio de Microbiología, Hospital Sant Joan de Déu, Barcelona.
Insights
Pediatric Streptococcus pyogenes show high macrolide resistance, particularly in skin infections. Penicillin and clindamycin remain effective, but susceptibility testing is advised for macrolide treatments.
Area of Science:
- Microbiology
- Infectious Diseases
- Pediatrics
Background:
- Streptococcus pyogenes is a common pediatric pathogen.
- Antibiotic resistance in S. pyogenes impacts treatment efficacy.
- Understanding local resistance patterns is crucial for effective therapy.
Purpose of the Study:
- To determine the current sensitivity of pediatric Streptococcus pyogenes strains to penicillin, clindamycin, clarithromycin, erythromycin, and azithromycin.
- To assess macrolide resistance prevalence in pediatric S. pyogenes isolates.
- To compare antibiotic susceptibility between pharyngeal and non-pharyngeal S. pyogenes strains.
Main Methods:
- Collected 100 S. pyogenes strains (79 pharyngeal, 21 non-pharyngeal) between October 1996 and July 1997.
- Determined Minimum Inhibitory Concentrations (MICs) using the E-test method.
- Validated results by comparing with the Kirby-Bauer disk diffusion method.
Main Results:
- All strains were sensitive to penicillin; one strain showed inducible resistance to clindamycin.
- 19% of strains exhibited macrolide resistance (clarithromycin, erythromycin, azithromycin).
- Higher resistance rates were observed in non-pharyngeal (28.5%) and cutaneous (4/6) samples compared to pharyngeal (16.5%) samples.
Conclusions:
- A significant level of macrolide resistance in pediatric S. pyogenes, especially from cutaneous sources, was confirmed.
- Penicillin and clindamycin demonstrated high susceptibility rates.
- In vitro susceptibility testing is recommended for macrolide chemotherapy due to declining susceptibility rates.
Background:
The purpose of this study was to set up the current level of Streptococcus pyogenes sensitivity, in pediatric patients in our community, to penicillin, clindamycin, clarithromycin, erythromycin and azithromycin.
Material And Methods:
100 strains were collected between October 1996 to July 1997. 79 were pharyngeal and 21 were non-pharyngeal strains. The MICs were obtained by the E-test method, and furthermore the results were compared by the Kirby-Bauer method.
Results:
All strains were sensitive to penicillin and except one (inducible resistance) to clindamycin. 19% were resistant to macrolide, without differences among clarithromycin, erythromycin and azithromycin. From 13 strains (16.5%) of pharyngeal and 6 (28.5%) from non-pharyngeal samples, 4 of these from cutaneous samples, showed resistance. 18 of the resistance strains belonged to novel resistance fenotip and one to 10 inducible fenotip. Only minor discrepancies about erythromycin and clindamycin were observed between E-test and Kirby-Bauer methods.
Conclusions:
This study confirms a remarkable level of resistance to macrolides in pediatric patients, mainly in the cutaneous samples. Due to the reduced prevalence of macrolide-susceptible strains, in vitro susceptibility testing appears necessary in case of macrolide chemotherapy.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Staphylococcal Skin Infections
Streptococcal Pharyngitis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

